Browse > Article

3D-QSAR Study of Competitive Inhibitor for Acethylcholine Esterase (AChE) Nerve Agent Toxicity  

San Juan, Amor A. (Biochemicals Research Center, Korea Institute of Science and Technology)
Cho, Seung-Joo (Biochemicals Research Center, Korea Institute of Science and Technology)
Publication Information
Molecular & Cellular Toxicology / v.2, no.3, 2006 , pp. 216-221 More about this Journal
Abstract
The cholinesterase-inhibiting organophosphorous (OP) compounds known as nerve agents are highly toxic. The principal toxic mechanism of OP compounds is the inhibition of acethylcholine esterase (AChE) by phosphorylation of its catalytic site. The reversible competitive inhibition of AChE may prevent the subsequent OP intoxication. In this study, three-dimensional quantitative structure-activity relationship (3D-QSAR) was performed to investigate the relationship between the 29 compounds with structural diversity and their bioactivities against AChE. In particular, predictive models were constructed using the comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA). The results indicate reasonable model for CoMFA ($q^{2}=0.453,\;r^{2}=0.697$) and CoMSIA ($q^{2}=0.518,\;r^{2}=0.696$). The presence of steric and hydophobic group at naphtyl moiety of the model may lead to the design of improved competitive inhibitors for organophosphorous intoxication.
Keywords
Acethylcholine esterase; Competitive inhibitors; CoMFA; CoMSIA; Nerve agent;
Citations & Related Records

Times Cited By Web Of Science : 0  (Related Records In Web of Science)
연도 인용수 순위
  • Reference
1 Kenley, R. et al. Nonquaternary cholinesterase reactivators. 2. ${\alpha}$-heteroaromatic aldoximes and thiohydroximates as reactivators of ethyl methylphosphonyl- acethylcholinesterase in vitro. J. Med. Chem. 27, 1201-1211 (1984)   DOI
2 Cramer, R.D.III, Bunce, J.D. & Patterson, D.E. Crossvalidation, bootstrapping, and partial least squares compared with multiple regression in conventional QSAR studies. Quant. Struct. Act. Relat. 7, 18-25 (1998)
3 Bai, D., Tang, X., He, X. & Huperzine, A. A potential therapeutic agent for treatment of Alzheimer's disease. Curr. Med. Chem. 7(3), 355-374 (2002)
4 Millard, C. et al. Reactivation products of acethylcholine and VX reveal a mobile histidine in the catalytic triad. J. Am. Chem. Soc. 121, 9883-9884 (1999)   DOI   ScienceOn
5 Kassa, J. Review of oximes in the antidotal treatment of poisoning by organophosphorous nerve agents. J. Toxicol.: Clin. Toxicol. 40, 803-816 (2002)   DOI   ScienceOn
6 SYBYL 7.0 (2004) Tripos Inc., 1699 Hanley Road, St. Louis, MO 63144
7 Golbraikh, A. & Tropsha, A. Beware of $q^2$! J. Mol. Graph. Model. 20, 269-276 (2002).   DOI   ScienceOn
8 Nachmansohn, D. Role of acetylcholine in neuromuscular transmission. Proc. Natl. Acad. Sci. U.S. 135(1), 136-149 (1966)
9 Bajgar, J. Prophylaxis against organophosphorous poisoning. J. Med. Chem. Def. 1, 1-16 (2004)
10 Bedford, C. et al. Nonquaternary cholinesterase reactivators. 4. dialkylaminoalkyl thioesters of ${\alpha}$-keto thiohydroximic acids as reactivators of ethyl methylphosphonyl- and 1, 2, 2-trimethylpropyl methylphosphonyl- acethylcholinesterase in vitro. J. Med. Chem. 29, 1689-1696 (1986)   DOI
11 Bedford, C. et al. Nonquaternary cholinesterase reacreactivators. 3. 3(5)-substituted 1, 2, 4-oxadiazol-5(3)- aldoximes and 1, 2, 4-oxadiazole-5(3)-thiocarbohydroximates as reactivators of organophosphateinhibited eel and human acethylcholinesterase in vitro. J. Med. Chem. 29, 2174-2183 (1986).   DOI
12 Bedford, C. et al. Structure-activity activity relationships for reactivators of organophosphorous-inhibited acethylcholinesterase: Quaternary salts of 2-[ (hydroxyimino) methyl]imidazole. J. Med. Chem. 27, 1431- 1438 (1984)   DOI